69 related articles for article (PubMed ID: 19372861)
1. Treatment interruption to boost specific HIV immunity in acute infection.
Kaufmann DE; Walker BD
Curr Opin HIV AIDS; 2007 Jan; 2(1):21-5. PubMed ID: 19372861
[TBL] [Abstract][Full Text] [Related]
2. Viral reservoirs and HIV-specific immunity.
Blankson JN
Curr Opin HIV AIDS; 2006 Mar; 1(2):147-51. PubMed ID: 19372799
[TBL] [Abstract][Full Text] [Related]
3. Treatment of acute HIV-1 infection: are we getting there?
Cellerai C; Little SJ; Loes SK
Curr Opin HIV AIDS; 2008 Jan; 3(1):67-74. PubMed ID: 19372946
[TBL] [Abstract][Full Text] [Related]
4. Acute HIV infection: it takes more than guts.
Mattapallil JJ; Roederer M
Curr Opin HIV AIDS; 2006 Jan; 1(1):10-5. PubMed ID: 19372777
[TBL] [Abstract][Full Text] [Related]
5. HIV vaccines: can mucosal CD4 T cells be protected?
Mattapallil JJ; Roederer M
Curr Opin HIV AIDS; 2006 Jul; 1(4):272-6. PubMed ID: 19372821
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic immunization in HIV infection.
Autran B; Kinloch-de Loes S; Katlama C
Curr Opin HIV AIDS; 2006 Jul; 1(4):323-9. PubMed ID: 19372828
[TBL] [Abstract][Full Text] [Related]
7. T-cell responses in primary HIV-1 infection.
Streeck H; van Bockel D; Kelleher A
Curr Opin HIV AIDS; 2008 Jan; 3(1):52-9. PubMed ID: 19372944
[TBL] [Abstract][Full Text] [Related]
8. Preparation for antiretroviral interruption by boosting the immune system.
Yves L
Curr Opin HIV AIDS; 2008 Mar; 3(2):118-23. PubMed ID: 19372952
[TBL] [Abstract][Full Text] [Related]
9. Role of HIV-1-specific CD4 T cells.
Harari A; Cellerai C; Pantaleo G
Curr Opin HIV AIDS; 2006 Jan; 1(1):22-7. PubMed ID: 19372779
[TBL] [Abstract][Full Text] [Related]
10. Stopping HAART temporarily in the absence of virus rebound: exploring new HIV treatment options.
Lori F; Foli A; Lisziewicz J
Curr Opin HIV AIDS; 2007 Jan; 2(1):14-20. PubMed ID: 19372860
[TBL] [Abstract][Full Text] [Related]
11. Monitoring clinical trials of therapeutic vaccines in HIV infection: role of treatment interruption.
Lederman MM; Penn-Nicholson A; Stone SF; Sieg SF; Rodriguez B
Curr Opin HIV AIDS; 2007 Jan; 2(1):56-61. PubMed ID: 19372866
[TBL] [Abstract][Full Text] [Related]
12. Early initiation of highly active antiretroviral therapy fails to reverse immunovirological abnormalities in gut-associated lymphoid tissue induced by acute HIV infection.
Tincati C; Biasin M; Bandera A; Violin M; Marchetti G; Piacentini L; Vago GL; Balotta C; Moroni M; Franzetti F; Clerici M; Gori A
Antivir Ther; 2009; 14(3):321-30. PubMed ID: 19474466
[TBL] [Abstract][Full Text] [Related]
13. The promise and challenge of anti-HIV cellular immunity.
Borrow P; Turnbull EL
Curr Opin HIV AIDS; 2006 Jul; 1(4):277-85. PubMed ID: 19372822
[TBL] [Abstract][Full Text] [Related]
14. Treatment interruption strategies: how great are the risks?
Paton NI
Curr Opin Infect Dis; 2008 Feb; 21(1):25-30. PubMed ID: 18192782
[TBL] [Abstract][Full Text] [Related]
15. Induction of novel CD8+ T-cell responses during chronic untreated HIV-1 infection by immunization with subdominant cytotoxic T-lymphocyte epitopes.
Kloverpris H; Karlsson I; Bonde J; Thorn M; Vinner L; Pedersen AE; Hentze JL; Andresen BS; Svane IM; Gerstoft J; Kronborg G; Fomsgaard A
AIDS; 2009 Jul; 23(11):1329-40. PubMed ID: 19528789
[TBL] [Abstract][Full Text] [Related]
16. Virological rebound and its consequences during treatment interruption.
van Lunzen J; Hoffmann C
Curr Opin HIV AIDS; 2007 Jan; 2(1):1-5. PubMed ID: 19372858
[TBL] [Abstract][Full Text] [Related]
17. Clade-specific differences in active viral replication and compartmentalization.
Sala M; Centlivre M; Wain-Hobson S
Curr Opin HIV AIDS; 2006 Mar; 1(2):108-14. PubMed ID: 19372793
[TBL] [Abstract][Full Text] [Related]
18. Treatment interruption as a tool to measure changes in immunologic response to HIV-1.
Kutzler MA; Jacobson JM
Curr Opin HIV AIDS; 2008 Mar; 3(2):131-5. PubMed ID: 19372954
[TBL] [Abstract][Full Text] [Related]
19. Combining antiretroviral drugs and immune therapies: an approach to achieve clinical benefit after treatment interruption.
Lisziewicz J
Curr Opin HIV AIDS; 2008 Mar; 3(2):104-11. PubMed ID: 19372950
[TBL] [Abstract][Full Text] [Related]
20. Risk of selecting resistance mutations during treatment interruption.
Martinez-Picado J; Wai Yan Tam L
Curr Opin HIV AIDS; 2007 Jan; 2(1):6-13. PubMed ID: 19372859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
